Does the impact of Markman orders vary by technology complexity?
Some patent litigators observe that patent disputes involving less complicated technologies tend to settle faster after claim construction. What does Docket Navigator data say?
Some patent litigators observe that patent disputes involving less complicated technologies tend to settle faster after claim construction. What does Docket Navigator data say?
Here’s the critical background to know as innovators today participate in a USPTO listening session about the intersection between standards development and IP
Following a lull in lawsuits, several new biologics have become the subject of litigation in recent months
05 May 2023
The vaccine maker has suffered another setback, but its fight to deflect infringement responsibility to the US government continues
02 May 2023
Planned change will make UPC more attractive to life sciences companies
28 April 2023
Various provisions in the USPTO’s rulemaking proposal favour patent owners and others lean towards petitioners, yet one thing is certain: chief IP officers must make their voices heard
26 April 2023
Illumina settlement and clean sweep at the PTAB have added to earlier $273 million damages award
26 April 2023
The company took a calculated risk by paying billions for drug while a slew of patent challenges were ongoing
25 April 2023
The Enlarged Board of Appeal's ruling in G2/21 has significant implications for the use of post-filed data
21 April 2023
Deal hoped to stave off investor concerns about expiring patents and diversify product pipeline
20 April 2023
With the European Commission increasingly ambivalent about patents, the UK has an opportunity to take leadership in areas such as SEP licensing and the life sciences
20 April 2023
Here's what you should know about the parties’ long-running battle over lucrative immuno-therapy patents
13 April 2023
Unlock unlimited access to all IAM content